|
|
lung development
|
GO:0030324 |
164 |
0.583
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.566
|
|
|
|
stem cell fate specification
|
GO:0048866 |
3 |
0.434
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.403
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.386
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.319
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.291
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.289
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.282
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.273
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.264
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.262
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.257
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.245
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.244
|
|
|
|
lung cell differentiation
|
GO:0060479 |
30 |
0.241
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.241
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.236
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.235
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.225
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.225
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.222
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.218
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.218
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.217
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.215
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.214
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.213
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.211
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.207
|
|
|
|
cell fate determination involved in pattern specification
|
GO:0060582 |
1 |
0.201
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.197
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.194
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.191
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.188
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.187
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.184
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.177
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.176
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.167
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.167
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.164
|
|
|
|
endocardial cell differentiation
|
GO:0060956 |
4 |
0.164
|
|
|
|
negative regulation of glial cell proliferation
|
GO:0060253 |
4 |
0.161
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.161
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.158
|
|
|
|
intra golgi vesicle mediated transport
|
GO:0006891 |
1 |
0.156
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.156
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.155
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.154
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.154
|
|
|
|
regulation of schwann cell proliferation
|
GO:0010624 |
2 |
0.152
|
|
|
|
branching involved in ureteric bud morphogenesis
|
GO:0001658 |
56 |
0.148
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.146
|
|
|
|
lung epithelium development
|
GO:0060428 |
37 |
0.145
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.144
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.140
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.136
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.135
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.133
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.131
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.129
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.129
|
|
|
|
clara cell differentiation
|
GO:0060486 |
4 |
0.125
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.124
|
|
|
|
negative regulation of chromosome organization
|
GO:2001251 |
30 |
0.119
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.117
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.117
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.116
|
|
|
|
compartment pattern specification
|
GO:0007386 |
4 |
0.115
|
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.114
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.113
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.112
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.111
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.109
|
|
|
|
mesenchymal cell proliferation
|
GO:0010463 |
44 |
0.109
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.106
|
|
|
|
neuroblast differentiation
|
GO:0014016 |
2 |
0.104
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.103
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.102
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.100
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.100
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.099
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.097
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.097
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.097
|
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.093
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.091
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.090
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.090
|
|
|
|
foregut morphogenesis
|
GO:0007440 |
12 |
0.090
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.089
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.089
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.088
|
|
|
|
regulation of asymmetric cell division
|
GO:0009786 |
4 |
0.088
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.087
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.086
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.086
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.085
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.085
|
|
|
|
negative regulation of bmp signaling pathway
|
GO:0030514 |
35 |
0.085
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.084
|
|
|
|
macromolecule deacylation
|
GO:0098732 |
37 |
0.084
|
|
|
|
neuroblast fate commitment
|
GO:0014017 |
1 |
0.083
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.083
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.083
|
|
|
|
neuroblast fate determination
|
GO:0007400 |
1 |
0.082
|
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.082
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.081
|
|
|
|
positive regulation of cell proliferation involved in heart valve morphogenesis
|
GO:0003251 |
1 |
0.081
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.080
|
|
|
|
regulation of protein deacetylation
|
GO:0090311 |
17 |
0.080
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.080
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.079
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.078
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.078
|
|
|
|
formation of anatomical boundary
|
GO:0048859 |
6 |
0.077
|
|
|
|
pigment accumulation
|
GO:0043476 |
1 |
0.077
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.077
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.075
|
|
|
|
sensory organ boundary specification
|
GO:0008052 |
1 |
0.075
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.075
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.075
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.074
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.073
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.073
|
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
34 |
0.073
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.073
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.071
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.070
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.070
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.070
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.069
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.069
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.069
|
|
|
|
regulation of cell cycle g2 m phase transition
|
GO:1902749 |
10 |
0.069
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.068
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.067
|
|
|
|
positive regulation of dna templated transcription elongation
|
GO:0032786 |
2 |
0.067
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.067
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.066
|
|
|
|
regulation of tolerance induction dependent upon immune response
|
GO:0002652 |
1 |
0.066
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.066
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.064
|
|
|
|
regulation of fibroblast proliferation
|
GO:0048145 |
34 |
0.064
|
|
|
|
striated muscle cell proliferation
|
GO:0014855 |
39 |
0.064
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
53 |
0.064
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.063
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.063
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.062
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.062
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.062
|
|
|
|
cerebellar granule cell precursor tangential migration
|
GO:0021935 |
1 |
0.061
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.061
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.061
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.060
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.060
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.059
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.059
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.058
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.058
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.058
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.058
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.057
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.057
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.056
|
|
|
|
cardiac right ventricle formation
|
GO:0003219 |
3 |
0.056
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.056
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.056
|
|
|
|
gene silencing by rna
|
GO:0031047 |
19 |
0.055
|
|
|
|
glomerular mesangial cell differentiation
|
GO:0072008 |
3 |
0.055
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.055
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.054
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.054
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.054
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.053
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.053
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.053
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.053
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.053
|
|
|
|
arterial endothelial cell differentiation
|
GO:0060842 |
5 |
0.052
|
|
|
|
negative regulation of osteoblast proliferation
|
GO:0033689 |
4 |
0.052
|
|
|
|
regulation of mesenchymal cell proliferation involved in lung development
|
GO:2000790 |
2 |
0.052
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.052
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.051
|
|
|
|
positive regulation of chromatin modification
|
GO:1903310 |
28 |
0.051
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.051
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.051
|
|
|
|
positive regulation of chromatin binding
|
GO:0035563 |
3 |
0.050
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.050
|
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
58 |
0.049
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.049
|
|
|
|
atrioventricular node development
|
GO:0003162 |
3 |
0.049
|
|
|
|
pro t cell differentiation
|
GO:0002572 |
3 |
0.048
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.048
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.048
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.048
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.047
|
|
|
|
formation of radial glial scaffolds
|
GO:0021943 |
4 |
0.047
|
|
|
|
immature b cell differentiation
|
GO:0002327 |
10 |
0.047
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
40 |
0.047
|
|
|
|
cell proliferation in forebrain
|
GO:0021846 |
30 |
0.047
|
|
|
|
mesangial cell differentiation
|
GO:0072007 |
4 |
0.046
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.046
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.046
|
|
|
|
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development
|
GO:0060528 |
4 |
0.046
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.046
|
|
|
|
nephrogenic mesenchyme morphogenesis
|
GO:0072134 |
2 |
0.046
|
|
|
|
face morphogenesis
|
GO:0060325 |
29 |
0.046
|
|
|
|
negative regulation of leukocyte proliferation
|
GO:0070664 |
46 |
0.046
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.046
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.046
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.046
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.045
|
|
|
|
regulation of mesenchymal cell proliferation
|
GO:0010464 |
37 |
0.045
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.045
|
|
|
|
somatic diversification of immune receptors
|
GO:0002200 |
53 |
0.045
|
|
|
|
negative regulation of mesenchymal cell proliferation involved in lung development
|
GO:2000791 |
2 |
0.044
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
57 |
0.044
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
42 |
0.044
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.044
|
|
|
|
cell proliferation involved in heart valve morphogenesis
|
GO:0003249 |
1 |
0.044
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.044
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.043
|
|
|
|
gene silencing by mirna
|
GO:0035195 |
10 |
0.043
|
|
|
|
reproductive behavior
|
GO:0019098 |
32 |
0.043
|
|
|
|
oligodendrocyte development
|
GO:0014003 |
20 |
0.043
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.042
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.042
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0036003 |
3 |
0.042
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.042
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.042
|
|
|
|
regulation of histone deacetylation
|
GO:0031063 |
12 |
0.041
|
|
|
|
head morphogenesis
|
GO:0060323 |
34 |
0.041
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.041
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.041
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.041
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.041
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.040
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.040
|
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
51 |
0.040
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.040
|
|
|
|
lymphocyte homeostasis
|
GO:0002260 |
64 |
0.040
|
|
|
|
thymus development
|
GO:0048538 |
41 |
0.040
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.039
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.039
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.039
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
42 |
0.039
|
|
|
|
negative regulation of histone modification
|
GO:0031057 |
18 |
0.039
|
|
|
|
negative regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030512 |
26 |
0.039
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.039
|
|
|
|
translation
|
GO:0006412 |
93 |
0.039
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.039
|
|
|
|
positive regulation of immature t cell proliferation
|
GO:0033091 |
4 |
0.038
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.038
|
|
|
|
cardiac endothelial cell differentiation
|
GO:0003348 |
4 |
0.038
|
|
|
|
calcium mediated signaling using intracellular calcium source
|
GO:0035584 |
3 |
0.038
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.038
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.038
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.037
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.037
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.037
|
|
|
|
regulation of cardiac cell fate specification
|
GO:2000043 |
1 |
0.036
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in cellular response to chemical stimulus
|
GO:1901522 |
7 |
0.036
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.036
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.036
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.036
|
|
|
|
negative regulation of mesenchymal cell proliferation
|
GO:0072201 |
3 |
0.036
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.035
|
|
|
|
multi organism reproductive behavior
|
GO:0044705 |
29 |
0.035
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.035
|
|
|
|
cell migration involved in endocardial cushion formation
|
GO:0003273 |
3 |
0.035
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.035
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.035
|
|
|
|
cell fate determination
|
GO:0001709 |
32 |
0.035
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.035
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.035
|
|
|
|
protein deacetylation
|
GO:0006476 |
32 |
0.035
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.035
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.035
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.035
|
|
|
|
negative regulation of calcium ion dependent exocytosis
|
GO:0045955 |
3 |
0.035
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.034
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.034
|
|
|
|
cytokine biosynthetic process
|
GO:0042089 |
68 |
0.034
|
|
|
|
lung morphogenesis
|
GO:0060425 |
50 |
0.034
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.034
|
|
|
|
negative regulation of chromatin modification
|
GO:1903309 |
19 |
0.034
|
|
|
|
rhombomere morphogenesis
|
GO:0021593 |
2 |
0.034
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.034
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.033
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.033
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.033
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.033
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.033
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.033
|
|
|
|
cell proliferation involved in heart valve development
|
GO:2000793 |
2 |
0.033
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.033
|
|
|
|
regulation of histone acetylation
|
GO:0035065 |
19 |
0.033
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.033
|
|
|
|
positive regulation of lymphocyte anergy
|
GO:0002913 |
4 |
0.033
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.033
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
45 |
0.033
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.033
|
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.033
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.032
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.032
|
|
|
|
regulation of g1 s transition of mitotic cell cycle
|
GO:2000045 |
35 |
0.032
|
|
|
|
endothelial cell differentiation
|
GO:0045446 |
41 |
0.032
|
|
|
|
formation of organ boundary
|
GO:0010160 |
1 |
0.031
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.031
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.031
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.031
|
|
|
|
cardiac muscle cell proliferation
|
GO:0060038 |
31 |
0.031
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.031
|
|
|
|
regulation of gliogenesis
|
GO:0014013 |
50 |
0.031
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
57 |
0.030
|
|
|
|
peripheral nervous system neuron axonogenesis
|
GO:0048936 |
3 |
0.030
|
|
|
|
posttranscriptional gene silencing
|
GO:0016441 |
10 |
0.030
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.030
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.030
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.030
|
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.030
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.030
|
|
|
|
lung epithelial cell differentiation
|
GO:0060487 |
29 |
0.030
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.030
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.030
|
|
|
|
embryonic digestive tract development
|
GO:0048566 |
27 |
0.030
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.030
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.029
|
|
|
|
fibroblast proliferation
|
GO:0048144 |
35 |
0.029
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.029
|
|
|
|
heart growth
|
GO:0060419 |
45 |
0.029
|
|
|
|
v d j recombination
|
GO:0033151 |
14 |
0.029
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.029
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.029
|
|
|
|
negative regulation of interleukin 5 production
|
GO:0032714 |
4 |
0.029
|
|
|
|
regulation of interleukin 2 secretion
|
GO:1900040 |
6 |
0.029
|
|
|
|
reflex
|
GO:0060004 |
22 |
0.028
|
|
|
|
metanephric mesenchyme morphogenesis
|
GO:0072133 |
4 |
0.028
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.028
|
|
|
|
regulation of lymphocyte anergy
|
GO:0002911 |
4 |
0.028
|
|
|
|
regulation of glial cell differentiation
|
GO:0045685 |
41 |
0.028
|
|
|
|
antimicrobial peptide biosynthetic process
|
GO:0002777 |
2 |
0.028
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.028
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.028
|
|
|
|
oligodendrocyte differentiation
|
GO:0048709 |
53 |
0.028
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.028
|
|
|
|
negative regulation of osteoblast differentiation
|
GO:0045668 |
30 |
0.028
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.027
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.027
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.027
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.027
|
|
|
|
rhombomere formation
|
GO:0021594 |
1 |
0.027
|
|
|
|
positive regulation of dendrite development
|
GO:1900006 |
21 |
0.027
|
|
|
|
mesodermal cell fate commitment
|
GO:0001710 |
17 |
0.027
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.027
|
|
|
|
maintenance of chromatin silencing
|
GO:0006344 |
2 |
0.027
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.027
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.027
|
|
|
|
male sex determination
|
GO:0030238 |
14 |
0.027
|
|
|
|
face development
|
GO:0060324 |
38 |
0.027
|
|
|
|
cell cycle arrest
|
GO:0007050 |
37 |
0.026
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.026
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.026
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.026
|
|
|
|
cd4 positive cd25 positive alpha beta regulatory t cell differentiation
|
GO:0002361 |
4 |
0.026
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.026
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.026
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.026
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.026
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.025
|
|
|
|
negative regulation of lymphocyte proliferation
|
GO:0050672 |
45 |
0.025
|
|
|
|
transforming growth factor beta1 production
|
GO:0032905 |
3 |
0.025
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.025
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.025
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.025
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.025
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.025
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.025
|
|
|
|
epithelial to mesenchymal transition involved in endocardial cushion formation
|
GO:0003198 |
10 |
0.025
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.025
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.025
|
|
|
|
regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045898 |
2 |
0.025
|
|
|
|
regulation of transcription from rna polymerase ii promoter in response to hypoxia
|
GO:0061418 |
2 |
0.025
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.024
|
|
|
|
extrinsic apoptotic signaling pathway via death domain receptors
|
GO:0008625 |
34 |
0.024
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.024
|
|
|
|
histone deacetylation
|
GO:0016575 |
26 |
0.024
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.024
|
|
|
|
astrocyte differentiation
|
GO:0048708 |
43 |
0.024
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.024
|
|
|
|
positive regulation of stem cell differentiation
|
GO:2000738 |
23 |
0.024
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.024
|
|
|
|
schwann cell proliferation
|
GO:0014010 |
2 |
0.024
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.024
|
|
|
|
glycerolipid biosynthetic process
|
GO:0045017 |
50 |
0.024
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.024
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.024
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.024
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.024
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.024
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.024
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.024
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
41 |
0.023
|
|
|
|
protein polyubiquitination
|
GO:0000209 |
33 |
0.023
|
|
|
|
cardiac muscle tissue growth
|
GO:0055017 |
37 |
0.023
|
|
|
|
protein dna complex disassembly
|
GO:0032986 |
1 |
0.023
|
|
|
|
definitive erythrocyte differentiation
|
GO:0060318 |
7 |
0.023
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.023
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.023
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.023
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.023
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.023
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.023
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.023
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.023
|
|
|
|
regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0043618 |
8 |
0.023
|
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.023
|
|
|
|
regulation of glial cell proliferation
|
GO:0060251 |
8 |
0.022
|
|
|
|
cardiac right atrium morphogenesis
|
GO:0003213 |
3 |
0.022
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.022
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.022
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.022
|
|
|
|
endothelium development
|
GO:0003158 |
45 |
0.022
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.022
|
|
|
|
regulation of t cell anergy
|
GO:0002667 |
4 |
0.022
|
|
|
|
glial cell fate commitment
|
GO:0021781 |
14 |
0.022
|
|
|
|
protein deacylation
|
GO:0035601 |
36 |
0.021
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.021
|
|
|
|
prostate glandular acinus development
|
GO:0060525 |
12 |
0.021
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.021
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.021
|
|
|
|
cellular response to acidic ph
|
GO:0071468 |
4 |
0.021
|
|
|
|
positive regulation of binding
|
GO:0051099 |
49 |
0.021
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.021
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.021
|
|
|
|
phosphatidylinositol 3 kinase signaling
|
GO:0014065 |
36 |
0.021
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.021
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
61 |
0.021
|
|
|
|
positive regulation of regulatory t cell differentiation
|
GO:0045591 |
4 |
0.021
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.021
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.021
|
|
|
|
negative regulation of photoreceptor cell differentiation
|
GO:0046533 |
4 |
0.021
|
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
35 |
0.021
|
|
|
|
regulation of proteasomal protein catabolic process
|
GO:0061136 |
46 |
0.021
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.021
|
|
|
|
t cell anergy
|
GO:0002870 |
4 |
0.021
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.021
|
|
|
|
histone h4 acetylation
|
GO:0043967 |
10 |
0.021
|
|
|
|
antimicrobial peptide production
|
GO:0002775 |
2 |
0.021
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.021
|
|
|
|
negative regulation of muscle cell differentiation
|
GO:0051148 |
33 |
0.021
|
|
|
|
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors
|
GO:1902043 |
13 |
0.021
|
|
|
|
hindbrain morphogenesis
|
GO:0021575 |
46 |
0.021
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.020
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.020
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.020
|
|
|
|
positive regulation of mitotic cell cycle phase transition
|
GO:1901992 |
17 |
0.020
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.020
|
|
|
|
negative regulation of interleukin 2 production
|
GO:0032703 |
8 |
0.020
|
|
|
|
cerebellum morphogenesis
|
GO:0021587 |
42 |
0.020
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.020
|
|
|
|
hindlimb morphogenesis
|
GO:0035137 |
42 |
0.020
|
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
10 |
0.020
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.020
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
51 |
0.020
|
|
|
|
inositol lipid mediated signaling
|
GO:0048017 |
41 |
0.020
|
|
|
|
glomerular mesangial cell development
|
GO:0072144 |
3 |
0.020
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.020
|
|
|
|
cell cell adhesion via plasma membrane adhesion molecules
|
GO:0098742 |
40 |
0.020
|
|
|
|
negative regulation of secretion by cell
|
GO:1903531 |
54 |
0.020
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.020
|
|
|
|
cd4 positive alpha beta t cell activation
|
GO:0035710 |
45 |
0.020
|
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.020
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.020
|
|
|
|
neural tube patterning
|
GO:0021532 |
43 |
0.020
|
|
|
|
interleukin 2 production
|
GO:0032623 |
33 |
0.019
|
|
|
|
regulation of transcription during meiosis
|
GO:0051037 |
1 |
0.019
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.019
|
|
|
|
blastocyst formation
|
GO:0001825 |
33 |
0.019
|
|
|
|
regulation of respiratory system process
|
GO:0044065 |
13 |
0.019
|
|
|
|
regulation of cellular ketone metabolic process by regulation of transcription from rna polymerase ii promoter
|
GO:0072364 |
7 |
0.019
|
|
|
|
prostate gland epithelium morphogenesis
|
GO:0060740 |
31 |
0.019
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.019
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.019
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.019
|
|
|
|
epithelial cell proliferation involved in prostate gland development
|
GO:0060767 |
11 |
0.019
|
|
|
|
oocyte anterior posterior axis specification
|
GO:0007314 |
2 |
0.019
|
|
|
|
membrane depolarization
|
GO:0051899 |
64 |
0.019
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.019
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.019
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.019
|
|
|
|
response to uv
|
GO:0009411 |
44 |
0.019
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.019
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.019
|
|
